American Century Companies’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Buy |
138,269
+6,748
| +5% | +$21K | ﹤0.01% | 2568 |
|
|
2025
Q1 | $445K | Buy |
131,521
+8,795
| +7% | +$29.7K | ﹤0.01% | 2555 |
|
|
2024
Q4 | $696K | Buy |
122,726
+9,190
| +8% | +$52.1K | ﹤0.01% | 2385 |
|
|
2024
Q3 | $664K | Sell |
113,536
-905,796
| -89% | -$5.3M | ﹤0.01% | 2376 |
|
|
2024
Q2 | $8.06M | Buy |
1,019,332
+249,659
| +32% | +$1.97M | ﹤0.01% | 1332 |
|
|
2024
Q1 | $7.17M | Buy |
769,673
+299,444
| +64% | +$2.79M | ﹤0.01% | 1340 |
|
|
2023
Q4 | $3.97M | Buy |
470,229
+157,324
| +50% | +$1.33M | ﹤0.01% | 1474 |
|
|
2023
Q3 | $2.43M | Buy |
312,905
+213,465
| +215% | +$1.65M | ﹤0.01% | 1624 |
|
|
2023
Q2 | $1.14M | Buy |
+99,440
| New | +$1.14M | ﹤0.01% | 1877 |
|
|
2020
Q2 | – | Sell |
-88,314
| Closed | -$808K | – | 1837 |
|
|
2020
Q1 | $808K | Buy |
88,314
+558
| +0.6% | +$5.11K | ﹤0.01% | 1035 |
|
|
2019
Q4 | $1.22M | Sell |
87,756
-68,478
| -44% | -$955K | ﹤0.01% | 1065 |
|
|
2019
Q3 | $2.69M | Buy |
156,234
+25,103
| +19% | +$432K | ﹤0.01% | 927 |
|
|
2019
Q2 | $3.57M | Sell |
131,131
-60,532
| -32% | -$1.65M | ﹤0.01% | 908 |
|
|
2019
Q1 | $3.67M | Buy |
191,663
+166,687
| +667% | +$3.19M | ﹤0.01% | 885 |
|
|
2018
Q4 | $235K | Buy |
+24,976
| New | +$235K | ﹤0.01% | 1197 |
|